We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+26.23%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$2.44B
AUM Growth
+$792M
Cap. Flow
+$442M
Cap. Flow %
18.15%
Top 10 Hldgs %
14.39%
Holding
5,222
New
2,059
Increased
1,821
Reduced
839
Closed
374

Sector Composition

Rank Sector Weight
1 Technology 12.14%
2 Healthcare 9.57%
3 Financials 8.79%
4 Industrials 7.76%
5 Consumer Discretionary 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HSDT icon
3676
Solana Company
HSDT
$99.3M
0
KEQU icon
3677
Kewaunee Scientific
KEQU
$104M
$20K ﹤0.01%
+2,100
New +$19.4K
LCUT icon
3678
Lifetime Brands
LCUT
$213M
$20K ﹤0.01%
+2,922
New +$15.7K
LRMR icon
3679
Larimar Therapeutics
LRMR
$417M
$20K ﹤0.01%
+1,565
New +$18.2K
MBIO icon
3680
Mustang Bio
MBIO
$4.47M
$20K ﹤0.01%
8
+3
+60% +$7.01K
NATR icon
3681
Nature's Sunshine
NATR
$277M
$20K ﹤0.01%
+2,183
New +$19K
ORGO icon
3682
Organogenesis Holdings
ORGO
$239M
$20K ﹤0.01%
+5,217
New +$18.8K
PSTL
3683
Postal Realty Trust
PSTL
$680M
$20K ﹤0.01%
1,273
-741
-37% -$11.7K
RDI icon
3684
Reading International Class A
RDI
$35.2M
$20K ﹤0.01%
4,640
-834
-15% -$3.15K
SGA icon
3685
Saga Communications
SGA
$61.4M
$20K ﹤0.01%
+770
New +$20.3K
SVRA icon
3686
Savara
SVRA
$1.17B
$20K ﹤0.01%
8,168
+4,836
+145% +$11.8K
UBFO
3687
DELISTED
United Security Bancshares
UBFO
$20K ﹤0.01%
+3,060
New +$19.2K
VRA icon
3688
Vera Bradley
VRA
$96.4M
$20K ﹤0.01%
+4,422
New +$22K
XERS icon
3689
Xeris Biopharma Holdings
XERS
$1.46B
$20K ﹤0.01%
7,563
+5,423
+253% +$18.9K
YUMC icon
3690
Yum China
YUMC
$16.5B
$20K ﹤0.01%
423
-11,187
-96% -$528K
ZYME icon
3691
Zymeworks
ZYME
$1.71B
$20K ﹤0.01%
+542
New +$20K
ARQ icon
3692
Arq
ARQ
$88.9M
$20K ﹤0.01%
4,084
+3,820
+1,447% +$22K
GHSI
3693
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
$20K ﹤0.01%
+149
New +$20.8K
AEPPL
3694
DELISTED
American Electric Power Company, Inc. Corporate Unit
AEPPL
$20K ﹤0.01%
412
+2
+0.5% +$100
GDP
3695
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
$20K ﹤0.01%
2,759
+959
+53% +$6.77K
SIC
3696
DELISTED
Select Interior Concepts, Inc. Class A Common Stock
SIC
$20K ﹤0.01%
+5,698
New +$16.7K
PFPT
3697
DELISTED
Proofpoint, Inc.
PFPT
$20K ﹤0.01%
+184
New +$21K
SCPE
3698
DELISTED
SC Health Corporation
SCPE
$20K ﹤0.01%
+1,888
New +$18.8K
FLY
3699
DELISTED
Fly Leasing Limited
FLY
$20K ﹤0.01%
+2,430
New +$16.9K
AMRN
3700
Amarin Corp
AMRN
$298M
$19K ﹤0.01%
141
-158
-53% -$21.7K

Similar funds

Tower Research Capital (TRC)'s Q2 2020 Portfolio in Review

As of Q2 2020, Tower Research Capital (TRC) held 5,222 positions worth $2.44B, up 48% from $1.64B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) deployed $442M of net new capital in Q2 2020, opening 2,059 new positions and adding to 1,821 existing holdings. Its largest new stake was Apple: 428,252 shares worth $39.1M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $342M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2020 buy was Apple: 428,252 shares worth $39.1M.
  • Tower Research Capital (TRC) added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, an estimated $55.3M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $342M.
  • Tower Research Capital (TRC) fully exited First Trust Technology AlphaDEX Fund in Q2 2020, selling an estimated $2.52M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $2.44B portfolio in Q2 2020.
  • Tower Research Capital (TRC) opened 2,059 new positions and closed 374 in Q2 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $2.44B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2020, filed 13 Aug 2020.